| Simultaneous Determination of pKa and Lipophilicity by Gradient RP HPLC P Wiczling, P Kawczak, A Nasal, R Kaliszan Analytical chemistry 78 (1), 239-249, 2006 | 120 | 2006 |
| Prediction of peptide retention at different HPLC conditions from multiple linear regression models T Ba̧czek, P Wiczling, M Marszałł, YV Heyden, R Kaliszan Journal of Proteome Research 4 (2), 555-563, 2005 | 120 | 2005 |
| Determination of pKa by pH Gradient Reversed-Phase HPLC P Wiczling, MJ Markuszewski, R Kaliszan Analytical Chemistry 76 (11), 3069-3077, 2004 | 113 | 2004 |
| pH gradient reversed-phase HPLC R Kaliszan, P Wiczling, MJ Markuszewski Analytical chemistry 76 (3), 749-760, 2004 | 81 | 2004 |
| Overview of experimental and computational methods for the determination of the pKa values of 5-fluorouracil, cyclophosphamide, ifosfamide, imatinib and methotrexate K Mioduszewska, J Dołżonek, D Wyrzykowski, Ł Kubik, P Wiczling, ... TrAC Trends in Analytical Chemistry 97, 283-296, 2017 | 80 | 2017 |
| Gradient HPLC in the determination of drug lipophilicity and acidity R Kaliszan, P Haber, T Baczek, D Siluk Pure and Applied Chemistry 73 (9), 1465-1475, 2001 | 74 | 2001 |
| Reversed-phase TLC and HPLC retention data in correlation studies with in silico molecular descriptors and druglikeness properties of newly synthesized anticonvulsant … N Perisic-Janjic, R Kaliszan, P Wiczling, N Milosevic, G Uscumlic, ... Molecular Pharmaceutics 8 (2), 555-563, 2011 | 69 | 2011 |
| pH gradient high-performance liquid chromatography: theory and applications R Kaliszan, P Wiczling, MJ Markuszewski Journal of Chromatography A 1060 (1-2), 165-175, 2004 | 61 | 2004 |
| Potential pitfalls of propofol target controlled infusion delivery related to its pharmacokinetics and pharmacodynamics A Bienert, P Wiczling, E Grzśkowiak, JB Cywiński, K Kusza Pharmacological reports 64 (4), 782-795, 2012 | 59 | 2012 |
| Population modeling of filgrastim PK‐PD in healthy adults following intravenous and subcutaneous administrations W Krzyzanski, P Wiczling, P Lowe, E Pigeolet, M Fink, A Berghout, ... The Journal of Clinical Pharmacology 50 (S9), 101S-112S, 2010 | 59 | 2010 |
| Least absolute shrinkage and selection operator and dimensionality reduction techniques in quantitative structure retention relationship modeling of retention in hydrophilic … E Daghir-Wojtkowiak, P Wiczling, S Bocian, Ł Kubik, P Kośliński, ... Journal of Chromatography A 1403, 54-62, 2015 | 53 | 2015 |
| pH/organic solvent double-gradient reversed-phase HPLC P Wiczling, MJ Markuszewski, M Kaliszan, R Kaliszan Analytical chemistry 77 (2), 449-458, 2005 | 53 | 2005 |
| Population pharmacokinetics of high-dose tigecycline in patients with sepsis or septic shock A Borsuk-De Moor, E Rypulak, B Potręć, P Piwowarczyk, M Borys, ... Antimicrobial agents and chemotherapy 62 (4), 10.1128/aac. 02273-17, 2018 | 49 | 2018 |
| Ultra-high performance liquid chromatographic determination of levofloxacin in human plasma and prostate tissue with use of experimental design optimization procedures O Szerkus, J Jacyna, P Wiczling, A Gibas, M Sieczkowski, D Siluk, ... Journal of Chromatography B 1029, 48-59, 2016 | 49 | 2016 |
| Pharmacokinetics and antibody responses to the CD3 antibody otelixizumab used in the treatment of type 1 diabetes G Hale, P Rebello, I Al Bakir, E Bolam, P Wiczling, WJ Jusko, ... The Journal of Clinical Pharmacology 50 (11), 1238-1248, 2010 | 47 | 2010 |
| Verification of the exponential model of body temperature decrease after death in pigs M Kaliszan, R Hauser, R Kaliszan, P Wiczling, J Buczyñski, M Penkowski Experimental Physiology 90 (5), 727-738, 2005 | 46 | 2005 |
| Pharmacokinetics and pharmacodynamics of a chimeric/humanized anti‐CD3 monoclonal antibody, otelixizumab (TRX4), in subjects with psoriasis and with type 1 diabetes mellitus P Wiczling, M Rosenzweig, L Vaickus, WJ Jusko The Journal of Clinical Pharmacology 50 (5), 494-506, 2010 | 45 | 2010 |
| The application of gradient reversed-phase high-performance liquid chromatography to the pKa and logkw determination of polyprotic analytes P Wiczling, M Waszczuk-Jankowska, MJ Markuszewski, R Kaliszan Journal of Chromatography A 1214 (1-2), 109-114, 2008 | 44 | 2008 |
| Pharmacokinetics and pharmacodynamics of propofol in patients undergoing abdominal aortic surgery P Wiczling, A Bienert, P Sobczyński, R Hartmann-Sobczyńska, K Bieda, ... Pharmacological Reports 64 (1), 113-122, 2012 | 41 | 2012 |
| The simultaneous determination of hydrophobicity and dissociation constant by liquid chromatography–mass spectrometry P Wiczling, W Struck-Lewicka, D Siluk, MJ Markuszewski, R Kaliszan Journal of Pharmaceutical and Biomedical Analysis 94, 180-187, 2014 | 37 | 2014 |
Roman Kaliszanprof., Medical University of GdańskVerified email at gumed.edu.pl
